CytoSwitch i.Gr.
CytoSwitch is a biotech startup developing tumour chemotherapeutics that have greatly reduced side-effects compared to current drugs. Our key advantage: we have a unique, patented antitumour drug that we can switch on selectively inside a tumour, by locally shining light into the tumour zone (eg by fibre optic or endoscope).
The technology is being further developed for cancer treatment, please see our webpage for further information:
Thorn-Seshold, c/o LMU Dept Pharmazie
5-13 Butenandtstr
Deutschland-81377 München
Telefon: 4915166958886
http://www.cytoswitch.com/
info@
cytoswitch.com